SABBY MANAGEMENT, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 73 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2021$712,000
-63.8%
137,239
-54.3%
0.10%
-60.9%
Q3 2021$1,965,000
-26.0%
300,000
-25.0%
0.27%
-28.9%
Q2 2021$2,656,000
-11.8%
400,050
-23.8%
0.37%
-36.2%
Q1 2021$3,010,000525,2300.59%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders